A detailed history of Boothbay Fund Management, LLC transactions in Organon & Co. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 30,761 shares of OGN stock, worth $453,109. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,761
Previous 109,669 71.95%
Holding current value
$453,109
Previous $2.27 Million 74.1%
% of portfolio
0.02%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $1.47 Million - $1.82 Million
-78,908 Reduced 71.95%
30,761 $588,000
Q2 2024

Aug 14, 2024

SELL
$17.45 - $21.96 $3.01 Million - $3.79 Million
-172,636 Reduced 61.15%
109,669 $2.27 Million
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $866,637 - $1.18 Million
-62,891 Reduced 18.22%
282,305 $5.31 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $132,615 - $209,762
-12,111 Reduced 3.39%
345,196 $4.98 Million
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $1.46 Million - $2.1 Million
88,286 Added 32.82%
357,307 $6.2 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $4.19 Million - $5.36 Million
217,445 Added 421.6%
269,021 $5.6 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $1.1 Million - $1.65 Million
51,576 New
51,576 $1.21 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $227,588 - $333,115
9,726 New
9,726 $228,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $217,175 - $281,259
-7,575 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $12.3 Million - $15.3 Million
-428,553 Reduced 98.26%
7,575 $248,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $12.4 Million - $16.6 Million
436,128 New
436,128 $13.2 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.